CSIS Issues Commentary: Rebuilding Resilience in U.S. Pharmaceutical Manufacturing
September 30, 2025
September 30, 2025
WASHINGTON, Sept. 30 -- The Center for Strategic and International Studies issued the following commentary on Sept. 29, 2025:
* * *
Rebuilding Resilience in U.S. Pharmaceutical Manufacturing
By Charles Wessner and Shruti Sharma
In May 2025, the Trump administration issued an executive order titled "Regulatory Relief to Promote Domestic Production of Critical Medicines" directing the Food and Drug Administration (FDA) and the Environme . . .
* * *
Rebuilding Resilience in U.S. Pharmaceutical Manufacturing
By Charles Wessner and Shruti Sharma
In May 2025, the Trump administration issued an executive order titled "Regulatory Relief to Promote Domestic Production of Critical Medicines" directing the Food and Drug Administration (FDA) and the Environme . . .